Gynecologic Cancer
From the Journals
CRS/HIPEC safety concerns may be outdated
In a retrospective study of more than 34,000 patients, CRS/HIPEC had a 30-day mortality rate of 1.1%, compared with rates of 2.5%-3.9% for other...
From the Journals
BMI changes in adolescence linked to later cancer risk
Adiposity changes during the peripubertal period may have more of an impact on ovarian cancer risk than adiposity changes during adulthood.
Case-Based Review
Epithelial Ovarian Cancer: Management of Advanced Disease
Case-Based Review
Epithelial Ovarian Cancer: Evaluation, Staging, Surgery, and Stage I and II Disease Management
From the Journals
Actionable mutations more likely in women with both breast and uterine cancer
At least one actionable mutation was seen in 14% of women with breast and uterine cancer, compared with 9.3% of women with breast cancer only, in...
News
FDA approves olaparib for maintenance treatment of BRCA-mutated advanced ovarian cancer
The FDA also approved a companion diagnostic, the BRACAnalysis CDx test, to identify patients with gBRCAm advanced epithelial ovarian, fallopian...
From the Journals
Low BMP-10 levels correlate with poor ovarian cancer survival
Studies of ovarian cancer tissues and cell lines suggest that bone morphogenetic protein-10 (BMP-10) may be a tumor suppressor.
From the Journals
HPV-16/-18 dramatically increases risk of high-grade CIN in young women
Women younger than 30 years who test positive for HPV-16/-18 are almost 10 times as likely to develop high-grade cervical intraepithelial...
From the Journals
Uterine cancer incidence and mortality on the rise in the U.S.
The incidence of and mortality from uterine cancer is increasing in the United States, particularly among nonwhite women.
Original Report
Patterns of malignancies in patients with HIV-AIDS: a single institution observational study
New Therapies
